sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Non Invasive Prenatal Testing Market Scope And Analysis

  • Report Code : TIPRE00005191
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Non-invasive Prenatal Testing Market Scope, Growth, Size and Share by 2031

Buy Now

Non-invasive Prenatal Testing Market Report Non-invasive Prenatal Testing Market Size and Share Non-invasive Prenatal Testing Market Scope and Analysis

Non-invasive Prenatal Testing Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Assay Kits and Reagents
  • Consumables
  • Disposables
  • Next-Generation Sequencing System
  • Instruments
  • PCR instruments
  • Ultrasound Devices
  • Microarrays
By Method
  • Ultrasound Detection
  • Cell-Free DNA in Maternal Plasma Tests
  • Biochemical Screening Tests
  • Fetal Cells in Maternal Plasma Tests
By Application
  • Trisomy
  • Micro Deletion Syndrome
By End User
  • Diagnostic Laboratories
  • Hospitals
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Ge Healthcare
  • Koninklijke Philips N V
  • Illumina Inc
  • Thermo Fisher Scientific Inc
  • F Hoffman La Roche Ltd
  • Pacific Biosciences of California Inc
  • Perkinelmer Inc
  • Qiagen N V
  • Agilent Technologies Inc